Dr. Reddy's launches generic version of Vimovo tablets in US market

28 Feb 2020 Evaluate

Dr. Reddy’s Laboratories has launched the first generic version of Vimovo tablets, used to treat rheumatoid arthritis, in the US market. The company announced the first-to-market launch of Naproxen and Esomeprazole Magnesium delayed-release tablets in the US market.

The company's product is the generic version of Vimovo tablets approved by the US Food and Drug Administration (USFDA).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×